Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI110622

Abnormal Renin Short Feedback Loop in Essential Hypertension Is Reversible with Converting Enzyme Inhibition

Meryl S. Leboff, Robert G. Dluhy, Norman K. Hollenberg, Thomas J. Moore, Richard J. Koletsky, and Gordon H. Williams

Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts 02115

Department of Radiology, Brigham and Women's Hospital, Boston, Massachusetts 02115

Find articles by Leboff, M. in: PubMed | Google Scholar

Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts 02115

Department of Radiology, Brigham and Women's Hospital, Boston, Massachusetts 02115

Find articles by Dluhy, R. in: PubMed | Google Scholar

Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts 02115

Department of Radiology, Brigham and Women's Hospital, Boston, Massachusetts 02115

Find articles by Hollenberg, N. in: PubMed | Google Scholar

Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts 02115

Department of Radiology, Brigham and Women's Hospital, Boston, Massachusetts 02115

Find articles by Moore, T. in: PubMed | Google Scholar

Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts 02115

Department of Radiology, Brigham and Women's Hospital, Boston, Massachusetts 02115

Find articles by Koletsky, R. in: PubMed | Google Scholar

Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts 02115

Department of Radiology, Brigham and Women's Hospital, Boston, Massachusetts 02115

Find articles by Williams, G. in: PubMed | Google Scholar

Published August 1, 1982 - More info

Published in Volume 70, Issue 2 on August 1, 1982
J Clin Invest. 1982;70(2):335–341. https://doi.org/10.1172/JCI110622.
© 1982 The American Society for Clinical Investigation
Published August 1, 1982 - Version history
View PDF
Abstract

The suppression of renin release by angiotensin II (AII) (the so-called short feedback loop) is blunted in essential hypertension. To determine whether this abnormality is reversible, renin release was assessed in sodium-restricted essential hypertensives and normal controls: (a) during the administration of captopril for varying intervals and (b) following the infusion of graded doses of AII (0.3-3 ng/kg per min) before and after plasma levels of AII had been chronically reduced with captopril (25-50 mg every 6 h) for 70 h.

In control subjects, the maximal increment above control in plasma renin activity (PRA) after a single dose of captopril (11.9±3 ng/ml per h) was significantly (P < 0.02) greater than in hypertensives (8.1±1.7 ng/ml per h) despite similar reductions in AII levels and significantly greater decrements in diastolic blood pressure in the hypertensives. When captopril was continued for 70 h, the PRA increments above base line in hypertensive subjects (11.4±2.9 ng/ml per h) rose to levels seen in the controls (11±2.6 ng/ml per h); there were no significant differences in the AII or diastolic blood pressure decrements between the two groups.

Compared with normotensive subjects, AII failed to suppress renin release in hypertensive subjects despite significantly greater diastolic blood increments and comparable AII levels achieved at each AII dose.

After captopril treatment, AII now produced significant declines in PRA in the hypertensives; moreover, comparing declines pre- and postcaptopril, greater PRA decrements were seen either at comparable rises in levels of AII or diastolic blood pressure. Finally, the suppression of PRA by AII postcaptopril in hypertensives was now indistinguishable from that seen in normal controls. Thus, the impaired regulation of renin by AII is reversible with prolonged captopril treatment, suggesting that this abnormality is not due to a fixed structural defect but to a reversible lesion.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 335
page 335
icon of scanned page 336
page 336
icon of scanned page 337
page 337
icon of scanned page 338
page 338
icon of scanned page 339
page 339
icon of scanned page 340
page 340
icon of scanned page 341
page 341
Version history
  • Version 1 (August 1, 1982): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts